he prevalence of type 2 diabetes has increased dramatically over the last 2 decades, and is predicted to double in a generation from 150 million in 2000 to 300 million by 2025 (1) . The majority of this increase is taking place in developing countries undergoing nutritional transition, and has a major impact on morbidity and healthcare resources (2; 3) . Although the precise pathophysiology of type 2 diabetes remains unclear, it is largely thought to be caused by a combination of the interaction between multiple genes and environmental factors (4) .
Single nucleotide polymorphism (SNP) analysis of genome variation in large cohorts have led to the identification of several genes being implicated in the pathogenesis of type 2 diabetes, of which TCF7L2 has been considered to be the most important to date (5) .
More recently, the first genome wide association study using 207 097 SNP markers in Asian (Japanese) patients with type 2 diabetes and unrelated controls was conducted. This led to the finding that polymorphisms (rs2237895, rs2237897, rs2283228) within a novel diabetes susceptibility gene, KCNQ1, were strongly associated with type 2 diabetes in the Japanese population (6; 7). Importantly, both studies corroborated these novel findings in populations of European and East Asian ancestry, including Chinese subjects living in Singapore (6) . Notwithstanding these promising findings, it is unclear whether these polymorphisms are associated with quantitative traits relevant to the pathogenesis of type 2 diabetes mellitus, primarily impaired β-cell function and insulin resistance (8) . Unoki et al. (6) did not report any association with β-cell function or insulin resistance, while only Yasuda et al. (7) found an association with β-cell function in Japanese (p=0.021) and Finnish subjects (p=0.024). To fill this knowledge gap, we aimed to investigate the association of these polymorphisms with a) insulin resistance and β-cell function and b) other quantitative metabolic risk phenotypes associated with type 2 diabetes within three different ethnicities (Chinese, Malay and Asian-Indian) living in Singapore.
METHODS

Subjects.
The study utilized data from the cross-sectional, population-based 1998 Singapore National Health Survey (NHS98, n=4723). Genotype data was available for 3734 subjects comprising of 2520 Chinese, 693 Malay, and 521 Asian-Indians. 1881 Chinese normal glucose tolerant (NGT) subjects had previously served as the controls for the Singapore replication arm in our original report [6] , while type 2 diabetes cases were from a separate study (the Singapore Diabetes Cohort Study). In this present study, all subjects (including subjects with NGT, impaired fasting glucose (IFG), impaired glucose tolerance (IGT) and type 2 diabetes) were derived from the NHS98 study. Details of the NHS98 survey have been previously described in greater detail (9 Insulin resistance (HOMA-IR) was estimated using the homeostasis model assessment method (HOMA) (10) . β-cell function was assessed using the corrected insulin response at 120 minutes (CIR 120 ) (11) . SNP genotyping. Genotyping of four SNPs in intron 15 of KCNQ1 rs2237897(c>T), rs2237895(A>C), rs2237892(C>T), and rs2283228(A>C) was performed using the TaqMan ® SNP genotyping assay (Applied Biosystems, Foster City, CA, USA). Genotyping success rate for rs2237897, rs2237895, rs2237892 and rs2283228 was 92%, 99%, 92% and 87% respectively. In order to assess reproducibility, 1% of samples were analyzed in duplicate; genotyping was 100% concordant for these samples. Statistical analysis. Minor allele frequency (MAF), Hardy-Weinberg equilibrium (HWE) and linkage disequilibrium (LD, reported using r 2 ) were estimated using Haploview (12) . The distribution of glucose and insulin measures were skewed and therefore normalized by natural logarithmic transformation.
Means were subsequently backtransformed for presentation. Quantitative traits are presented as means and standard deviations. Linear regression analyses were performed to study the associations between diabetesrelated traits with genotypic groups. Individuals were as assigned as 0/1/2 according to their number of minor alleles under an additive model of inheritance. There was no significant heterogeneity between the genders (p>0.05) and subsequent analyses were performed with the genders combined and adjusted for gender.
Linear regression with adjustment for ethnicity was used to estimate the summary effect size of the SNPs in the combined sample from the three ethnic groups. Logistic regression was used to estimate the association between KCNQ1 SNPs and type 2 diabetes. All analyses were stratified by ethnic group and adjusted for age, gender and BMI (where appropriate). Analysis of association with β-cell function was further adjusted for insulin resistance. (13) . Analyses were performed using STATA (version 9.1 for Windows) (14) .
RESULTS
The anthropometric and biochemical characteristics of the participants are detailed in Table 1 .
Amongst these individuals, there was a higher prevalence of type 2 diabetes among the Malay and Asian-Indian populations, and a lower mean BMI and fasting glucose level among the Chinese population.
Allele frequency for rs2237897, rs2237895, rs2237892 and rs2283228 were similar between the Chinese and Malays but different in Asian-Indians ( Figure 1 ). All SNPs in the Chinese and Malays were in HWE (p>0.05). In the Asian-Indians, three of the SNPs which had low MAF (rs2237897, rs2237892 and rs2283228) were not in HWE. Consequently, the results for the Asian-Indians should be interpreted with caution. Table 2 shows the association between KCNQ1 SNPs with type 2 diabetes in the Chinese, Malay and Asian-Indian population in Singapore. Significant associations were observed in the Chinese, with rs2237897 showing the strongest effect: OR=1.50 (1.15-1.96), p=0.003. In the combined sample of the three ethnic groups, the risk alleles of rs2237897(C), rs2237892(C) and rs2283228(A) were also associated with type 2 diabetes in our study, consistent with previous reports (6; 7). Of these, rs2237897 showed the strongest association (OR=1.48 (1.20-1.83), p=0.0003). In the combined sample of only Chinese and Malays subjects, the association with rs2237897 remained significant [OR=1.45 (1.16-1.81), p=0.001]. Table 3 shows the association between KCNQ1 SNPs with diabetesrelated traits.
The risk alleles for rs2237897, rs2237892 and rs2283228 showed statistically significant association with higher fasting glucose levels (p=0.014, 0.011 & 0.034 respectively) and reduced CIR 120 (p=0.007, 0.013 & 0.014 respectively) in the Chinese population. After restricting to subjects without diabetes, the association remained significant with CIR 120 (p=0.011, 0.020 & 0.015 respectively, Online appendix Table 1 ). A similar trend was observed among the Malays and Asian-Indians, though the associations did not reach statistical significance, possibly due to the limited sample sizes for these minority ethnic groups. In the combined analysis, rs2237897 and rs2237892 were significantly associated with fasting glucose levels (p=0.029 and p=0.021 respectively), while rs2237897, rs2237892 and rs2283228 were significantly associated with lower β-cell function (CIR 120 ) (p=0.013, 0.021 & 0.020 respectively). These SNPs also showed associations with BMI in the Malay population and waist-hip ratio (WHR) in Asian-Indians.
However these associations were no longer statistically significant in the combined analysis. Based on a risk allele frequency of between 0.3-0.6, power calculations estimate that the combined sample provided 90% power to detect a 10% change in the examined traits.
DISCUSSION
Polymorphisms within KCNQ1 have recently been shown to be strongly associated with an increased risk of type 2 diabetes in the East Asian and European populations (6; 7). Of the three polymorphisms within KCNQ1 previously described, rs2237897 appeared to have the strongest association with type 2 diabetes (6), whilst another study reported the strongest association with rs2237892 (7). Consistent with these findings, we found that both these SNPs were significantly associated with type 2 diabetes in the combined analysis of three ethnic groups. In addition, the presence of the risk allele for KCNQ1 variants rs2237897, rs2237892 and rs2283228 were associated with increased fasting glucose level and decreased β-cell function in the Chinese population and combined sample. This is in agreement with the study by Yasuda et al. (7) , which reported an association of these KCNQ1 variants with β-cell function.
Together, these findings corroborate the hypothesis that the role of this protein in the pathogenesis of type 2 diabetes is likely mediated through its effects on the pancreatic β cell, although there is still a possibility that these polymorphisms may increase the risk of type 2 diabetes through regulation of nearby genes. In contrast, there was no association between rs2237895 with any diabetes related traits, specifically highlighting the importance of these polymorphisms rs2237897, rs2237892 and rs2283228 (which are in moderate LD), in increasing the risk of developing type 2 diabetes. Further fine mapping of SNPs in KCNQ1, especially within the LD block containing rs2237897 and rs2237892 may allow the identification of the causal variant.
KCNQ1 is located on 11p15.5, which encodes the pore-forming α-subunit of the I KS K + channel, which is expressed mainly in the heart, and to a lesser extent, the inner ear, stomach, small and large intestine, liver and kidney. KCNQ1 is also expressed in the pancreas where it is co-expressed with products of other regulators such as KCNE1, which may alter its biophysical characteristics and role (15) . As such, it is plausible that polymorphisms within the KCNQ1 gene alter the properties and role of I KS K + channel, causing decreased pancreatic β-cell function and insulin production, leading eventually to hyperglycaemia.
While we do appreciate that the associations observed in the Chinese do not represent an independent replication since the controls used are largely the same as those in the study by Unoki et al. (6) , we have provided data on Malays and Indians and in our opinion, it was reassuring that similar trends for an effect of these 3 polymorphisms on association with type 2 diabetes, fasting glucose and β-cell function were also observed in the Malay and Asian-Indian subjects, even though their limited numbers certainly resulted in a reduction of study power. Although associations with BMI in Malays and WHR in Asian Indians were found, the smaller sample sizes for these ethnic groups, together with the fact that these observations were not found in other ethnic groups, inevitably led us to be cautious in interpreting these findings. One caveat of this study is that we only examined the SNPs, which showed the strongest association, identified by Unoki et al. [6] and Yasuda et al. [7] . While the Chinese show strong and consistent associations with these SNPs, the association among Malays and AsianIndians is less clear.
Further fine mapping of the KCNQ1 locus, for instance, through deep DNA resequencing may allow the identification of population-specific causative variants.
The use of CIR 120 represented a limitation of our study since it only served as an approximate measure of β-cell function, which may be better assessed using the CIR 30 .
Thus, if CIR 30 measurements were available, the positive associations that had been observed in our study may be further strengthened.
It has also been suggested that CIR 120 could inadvertently capture information on additional aspects of glucose intolerance instead of insulin secretion alone. The previous finding of the association between CIR 30 with KCNQ1 SNPs, in non-diabetic European subjects of the Botnia prospective study during their follow-up visit (p = 0.024) (7), however appeared to corroborate our hypothesis that these SNPs may exert their effect on type 2 diabetes through an effect on insulin secretion.
In conclusion, the risk alleles of rs2237897, rs2237892 and rs2283228 within the KCNQ1 gene are associated with decreased pancreatic β-cell function and fasting glucose levels, suggesting that the impact of these polymorphisms on the risk of type 2 diabetes may be mediated through an impact on β-cell function rather than insulin resistance. Further studies will be useful to replicate these promising findings and to fully delineate the role of KCNQ1 and its related pathways in the pathogenesis of type 2 diabetes. 
